Wells Fargo Strategic Capital

Wells Fargo Strategic Capital is the specialized equity investment arm of Wells Fargo, providing growth capital tailored to healthcare technology companies among other sectors. Headquartered in Charlotte, the group draws on the broader bank’s lending, treasury, and corporate relationships, giving it a distinctive corporate VC profile. Its healthcare focus is concentrated in Health IT and healthcare software. Wells Fargo Strategic Capital is not branded as an AI-specialist investor, so AI-enabled clinical software is most likely to be evaluated as part of a broader healthcare technology growth thesis rather than through a dedicated AI lens.

The team invests at the growth stage with check sizes between $5M and $25M, sitting in the lower-to-middle market and frequently co-investing alongside lead institutional firms. Activity is U.S.-focused and generally involves minority positions in companies with proven revenue and a clear path to scale. Founders may also benefit from broader bank relationships in lending, treasury, and capital markets when their company matures.

Limited public information is available about the team’s specific healthcare AI deal cadence. Founders should approach with strong revenue metrics, capital-efficient growth profiles, and a credible institutional financing story. Banker introductions, syndicate partners, and existing Wells Fargo commercial relationships are the most effective inbound routes, and pitches that address both equity needs and broader banking utility tend to be received more constructively than pure venture-style narratives.